BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Interferon α/β receptor 1 (IFNAR1); tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)

March 31, 2016 7:00 AM UTC

Cell culture and mouse studies suggest that combining inhibitors of IFNAR1 and TRAIL could help treat acute respiratory distress syndrome (ARDS) and other types of acute lung injury (ALI) caused by in...